ID   MARH2_RAT               Reviewed;         246 AA.
AC   Q5I0I2;
DT   06-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   15-FEB-2005, sequence version 1.
DT   29-MAY-2024, entry version 135.
DE   RecName: Full=E3 ubiquitin-protein ligase MARCHF2;
DE            EC=2.3.2.27 {ECO:0000250|UniProtKB:Q9P0N8};
DE   AltName: Full=Membrane-associated RING finger protein 2;
DE   AltName: Full=Membrane-associated RING-CH protein II;
DE            Short=MARCH-II;
DE   AltName: Full=RING finger protein 172 {ECO:0000250|UniProtKB:Q9P0N8};
DE            Short=RNF172;
DE   AltName: Full=RING-type E3 ubiquitin transferase MARCHF2 {ECO:0000305};
GN   Name=Marchf2; Synonyms=March2, Rnf172;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, SUBCELLULAR LOCATION,
RP   INTERACTION WITH STX6, AND FUNCTION.
RC   TISSUE=Small intestine;
RX   PubMed=15689499; DOI=10.1091/mbc.e04-03-0216;
RA   Nakamura N., Fukuda H., Kato A., Hirose S.;
RT   "MARCH-II is a syntaxin-6-binding protein involved in endosomal
RT   trafficking.";
RL   Mol. Biol. Cell 16:1696-1710(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thymus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   INTERACTION WITH MARCHF3.
RX   PubMed=16428329; DOI=10.1093/jb/mvj012;
RA   Fukuda H., Nakamura N., Hirose S.;
RT   "MARCH-III is a novel component of endosomes with properties similar to
RT   those of MARCH-II.";
RL   J. Biochem. 139:137-145(2006).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase that may mediate ubiquitination
CC       of TFRC and CD86, and promote their subsequent endocytosis and sorting
CC       to lysosomes via multivesicular bodies. E3 ubiquitin ligases accept
CC       ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a
CC       thioester and then directly transfer the ubiquitin to targeted
CC       substrates. Together with GOPC/CAL mediates the ubiquitination and
CC       lysosomal degradation of CFTR (By similarity). Ubiquitinates and
CC       therefore mediates the degradation of DLG1 (By similarity). Regulates
CC       the intracellular trafficking and secretion of alpha1-
CC       antitrypsin/SERPINA1 and HP/haptoglobin via ubiquitination and
CC       degradation of the cargo receptor ERGIC3 (By similarity). Negatively
CC       regulates the antiviral and antibacterial immune response by repression
CC       of the NF-kB and type 1 IFN signaling pathways, via MARCHF2-mediated
CC       K48-linked polyubiquitination of IKBKG/NEMO, resulting in its
CC       proteasomal degradation (By similarity). May be involved in endosomal
CC       trafficking through interaction with STX6.
CC       {ECO:0000250|UniProtKB:Q9P0N8, ECO:0000269|PubMed:15689499}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27; Evidence={ECO:0000250|UniProtKB:Q9P0N8};
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000250|UniProtKB:Q9P0N8}.
CC   -!- SUBUNIT: Interacts with STX6; the interaction promotes MARCHF2-mediated
CC       ubiquitination and degradation of CFTR (PubMed:15689499). Interacts
CC       with MARCHF3 (PubMed:16428329). Interacts with GOPC/CAL; the
CC       interaction leads to CFTR ubiquitination and degradation (By
CC       similarity). Interacts with CFTR; the interaction leads to CFTR
CC       ubiqtuitination and degradation (By similarity). Interacts (via PDZ
CC       domain) with DLG1 (via PDZ domains); the interaction leads to DLG1
CC       ubiqtuitination and degradation (By similarity). Interacts with ERGIC3
CC       (By similarity). Interacts with ADRB2 (By similarity). Interacts with
CC       IKBKG/NEMO; during the late stages of macrophage viral and bacterial
CC       infection; the interaction leads to ubiquitination and degradation of
CC       IKBKG/NEMO (By similarity). {ECO:0000250|UniProtKB:Q9P0N8,
CC       ECO:0000269|PubMed:15689499, ECO:0000269|PubMed:16428329}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:15689499}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:15689499}. Lysosome membrane
CC       {ECO:0000250|UniProtKB:Q9P0N8}; Multi-pass membrane protein
CC       {ECO:0000255}. Endosome membrane {ECO:0000269|PubMed:15689499}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:15689499}. Golgi apparatus
CC       membrane {ECO:0000250|UniProtKB:Q9P0N8}; Multi-pass membrane protein
CC       {ECO:0000255}. Cytoplasm {ECO:0000250|UniProtKB:Q9P0N8}. Cell membrane
CC       {ECO:0000250|UniProtKB:Q9P0N8}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Present in liver (at
CC       protein level). {ECO:0000269|PubMed:15689499}.
CC   -!- DOMAIN: The RING-CH-type zinc finger domain is required for E3 ligase
CC       activity. {ECO:0000255|PROSITE-ProRule:PRU00623}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB048838; BAD89357.1; -; mRNA.
DR   EMBL; BC088286; AAH88286.1; -; mRNA.
DR   RefSeq; NP_001029280.1; NM_001034108.1.
DR   AlphaFoldDB; Q5I0I2; -.
DR   SMR; Q5I0I2; -.
DR   BioGRID; 263774; 7.
DR   STRING; 10116.ENSRNOP00000010399; -.
DR   PhosphoSitePlus; Q5I0I2; -.
DR   PaxDb; 10116-ENSRNOP00000010399; -.
DR   Ensembl; ENSRNOT00000010399.8; ENSRNOP00000010399.5; ENSRNOG00000007769.8.
DR   GeneID; 362849; -.
DR   KEGG; rno:362849; -.
DR   UCSC; RGD:1306395; rat.
DR   AGR; RGD:1306395; -.
DR   CTD; 51257; -.
DR   RGD; 1306395; Marchf2.
DR   eggNOG; KOG1609; Eukaryota.
DR   GeneTree; ENSGT00940000158995; -.
DR   HOGENOM; CLU_096532_0_0_1; -.
DR   InParanoid; Q5I0I2; -.
DR   OrthoDB; 1342875at2759; -.
DR   PhylomeDB; Q5I0I2; -.
DR   TreeFam; TF319557; -.
DR   UniPathway; UPA00143; -.
DR   PRO; PR:Q5I0I2; -.
DR   Proteomes; UP000002494; Chromosome 7.
DR   Bgee; ENSRNOG00000007769; Expressed in skeletal muscle tissue and 19 other cell types or tissues.
DR   ExpressionAtlas; Q5I0I2; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0031410; C:cytoplasmic vesicle; ISS:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0010008; C:endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0000139; C:Golgi membrane; ISO:RGD.
DR   GO; GO:0005765; C:lysosomal membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; ISS:UniProtKB.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0140367; P:antibacterial innate immune response; ISS:UniProtKB.
DR   GO; GO:0140374; P:antiviral innate immune response; ISS:UniProtKB.
DR   GO; GO:0006897; P:endocytosis; IEA:UniProtKB-KW.
DR   GO; GO:1905167; P:positive regulation of lysosomal protein catabolic process; ISO:RGD.
DR   GO; GO:0016567; P:protein ubiquitination; ISS:UniProtKB.
DR   GO; GO:0044790; P:suppression of viral release by host; ISO:RGD.
DR   CDD; cd16808; RING_CH-C4HC3_MARCH2; 1.
DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR011016; Znf_RING-CH.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   PANTHER; PTHR46065; E3 UBIQUITIN-PROTEIN LIGASE MARCH 2/3 FAMILY MEMBER; 1.
DR   PANTHER; PTHR46065:SF4; E3 UBIQUITIN-PROTEIN LIGASE MARCHF2; 1.
DR   Pfam; PF12906; RINGv; 1.
DR   SMART; SM00744; RINGv; 1.
DR   SUPFAM; SSF57850; RING/U-box; 1.
DR   PROSITE; PS51292; ZF_RING_CH; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Cytoplasm; Endocytosis; Endoplasmic reticulum; Endosome;
KW   Golgi apparatus; Lysosome; Membrane; Metal-binding; Reference proteome;
KW   Transferase; Transmembrane; Transmembrane helix; Ubl conjugation pathway;
KW   Zinc; Zinc-finger.
FT   CHAIN           1..246
FT                   /note="E3 ubiquitin-protein ligase MARCHF2"
FT                   /id="PRO_0000274503"
FT   TRANSMEM        138..158
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        175..195
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   ZN_FING         56..116
FT                   /note="RING-CH-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00623"
FT   REGION          121..246
FT                   /note="Required for interaction with IKBKG"
FT                   /evidence="ECO:0000250|UniProtKB:Q9P0N8"
FT   BINDING         64
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00623"
FT   BINDING         67
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00623"
FT   BINDING         80
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00623"
FT   BINDING         82
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00623"
FT   BINDING         90
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00623"
FT   BINDING         93
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00623"
FT   BINDING         106
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00623"
FT   BINDING         109
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00623"
SQ   SEQUENCE   246 AA;  27169 MW;  346711F2FF28FF25 CRC64;
     MTTGDCCHLP GSLCDCSSSP AFSKVVEATG LGPPQYVAQV TSRDGRLLST VIRALDTPSD
     CPFCRICHEG ANGENLLSPC GCTGTLGAVH KSCLEKWLSS SNTSYCELCH TEFAVEKRPR
     PLTEWLKDPG PRTEKRTLCC DMVCFVFITP LAAISGWLCL RGAQDHLRLH SRLEAVGLIA
     LTIALFTIYV LWTLVSFRYH CQLYSEWRKT NQKVRLKIRE ADGSEDPHHS LLATGLLKKV
     AEETPV
//
